Patent applications and USPTO patent grants for Pharmacyclics LLC.The latest application filed is for "use of inhibitors of brutons tyrosine kinase (btk)".
Patent | Date |
---|---|
Use Of Inhibitors Of Brutons Tyrosine Kinase (btk) App 20220249494 - Buggy; Joseph J. ;   et al. | 2022-08-11 |
Co-crystals Of A Bruton's Tyrosine Kinase Inhibitor App 20220242868 - Goldman; Erick ;   et al. | 2022-08-04 |
Inhibitors of Bruton's Tyrosine Kinase App 20220213106 - Buggy; Joseph J. ;   et al. | 2022-07-07 |
Use Of Inhibitors Of Brutons Tyrosine Kinase (btk) App 20220175785 - Buggy; Joseph J. ;   et al. | 2022-06-09 |
Crystalline Forms Of A Brutons Tyrosine Kinase Inhibitor App 20220112196 - Purro; Norbert ;   et al. | 2022-04-14 |
Solvated Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20220106317 - Goldman; Erick ;   et al. | 2022-04-07 |
Synthesis Of A Bruton's Tyrosine Kinase Inhibitor App 20220098200 - Ben Haim; Cyril ;   et al. | 2022-03-31 |
Inhibitors Of Bruton's Tyrosine Kinase App 20220008424 - Honigberg; Lee ;   et al. | 2022-01-13 |
Use Of Inhibitors Of Brutons Tyrosine Kinase (btk) App 20210361657 - Buggy; Joseph J. ;   et al. | 2021-11-25 |
Methods Of Treating And Preventing Alloantibody Driven Chronic Graft Versus Host Disease App 20210177854 - Blazar; Bruce R. ;   et al. | 2021-06-17 |
Use Of Inhibitors Of Brutons Tyrosine Kinase (btk) App 20210169885 - Buggy; Joseph J. ;   et al. | 2021-06-10 |
Methods For The Treatment Of Her2 Amplified Cancer App 20210145835 - Chen; Jun ;   et al. | 2021-05-20 |
Methods Of Treating And Preventing Graft Versus Host Disease App 20210121463 - Byrd; John C. ;   et al. | 2021-04-29 |
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant 10,961,251 - Purro , et al. March 30, 2 | 2021-03-30 |
Mutations associated with resistance to inhibitors of Bruton's Tyrosine Kinase (BTK) Grant 10,954,567 - Chang , et al. March 23, 2 | 2021-03-23 |
Crystalline Forms Of A Brutons Tyrosine Kinase Inhibitor App 20210070759 - Purro; Norbert ;   et al. | 2021-03-11 |
Inhibitors Of Brutons Tyrosine Kinase App 20210070748 - Atallah; Gordana B. ;   et al. | 2021-03-11 |
Crystalline Forms Of A Brutons Tyrosine Kinase Inhibitor App 20210032258 - Purro; Norbert ;   et al. | 2021-02-04 |
Salts of 3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl) phenoxy]ethyli-1-benzofuran-2-carboxamide, related crystalline forms, method for preparing the same and pharmaceutical compositions containing the same Grant 10,898,461 - Gaillard , et al. January 26, 2 | 2021-01-26 |
Treatment Using Bruton's Tyrosine Kinase Inhibitors And Immunotherapy App 20200397895 - Levy; Ronald ;   et al. | 2020-12-24 |
Ibrutinib Combination Therapy App 20200368235 - Chang; Betty ;   et al. | 2020-11-26 |
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor Grant 10,828,259 - Chong , et al. November 10, 2 | 2020-11-10 |
Synthesis Of A Bruton's Tyrosine Kinase Inhibitor App 20200347064 - Ben Haim; Cyril ;   et al. | 2020-11-05 |
Solvated Forms Of A Bruton?s Tyrosine Kinase Inhibitor App 20200347063 - Goldman; Erick ;   et al. | 2020-11-05 |
Inhibitors Of Bruton's Tyrosine Kinase For The Treatment Of Solid Tumors App 20200289515 - Honigberg; Lee ;   et al. | 2020-09-17 |
Inhibitors Of Bruton's Tyrosine Kinase For The Treatment Of Solid Tumors App 20200276199 - Buggy; Joseph J. ;   et al. | 2020-09-03 |
Use of inhibitors of Bruton's tyrosine kinase (Btk) Grant 10,751,342 - Buggy , et al. A | 2020-08-25 |
Crystalline forms of a brutons tyrosine kinase inhibitor Grant 10,752,634 - Purro , et al. A | 2020-08-25 |
Methods Of Treating Abc-dlbcl Using Inhibitors Of Brutons Tyrosine Kinase App 20200246259 - Kind Code | 2020-08-06 |
Pharmaceutical Formulations Of A Bruton's Tyrosine Kinase Inhibitor App 20200237673 - Chong; Ching W. ;   et al. | 2020-07-30 |
Crystalline Forms Of A Brutons Tyrosine Kinase Inhibitor App 20200231595 - Purro; Norbert ;   et al. | 2020-07-23 |
Crystalline Forms Of A Brutons Tyrosine Kinase Inhibitor App 20200223856 - Purro; Norbert ;   et al. | 2020-07-16 |
Methods of treating and preventing graft versus host disease Grant 10,695,350 - Byrd , et al. | 2020-06-30 |
Use Of Inhibitors Of Brutons Tyrosine Kinase (btk) App 20200163968 - Buggy; Joseph J. ;   et al. | 2020-05-28 |
Use of inhibitors of bruton's tyrosine kinase (BTK) Grant 10,653,696 - Buggy , et al. | 2020-05-19 |
Crystalline Forms Of A Brutons Tyrosine Kinase Inhibitor App 20200148691 - Purro; Norbert ;   et al. | 2020-05-14 |
Tec Family Kinase Inhibitor Adjuvant Therapy App 20200147084 - Buggy; Joseph J. ;   et al. | 2020-05-14 |
Inhibitors Of Bruton's Tyrosine Kinase App 20200108072 - Honigberg; Lee ;   et al. | 2020-04-09 |
Inhibitors Of Brutons Tyrosine Kinase App 20200079754 - Chen; Wei ;   et al. | 2020-03-12 |
Novel Salts Of 3-[(dimethylamino)methyl]-n-{2-[4-(hydroxycarbamoyl) Phenoxy]ethyli-1-benzofuran-2-carboxamide, Related Crystalli App 20200069637 - Gaillard; Marina ;   et al. | 2020-03-05 |
Inhibitors Of Brutons Tyrosine Kinase App 20200055859 - Buggy; Joseph J. ;   et al. | 2020-02-20 |
Co-crystals Of A Bruton's Tyrosine Kinase Inhibitor App 20200031829 - Goldman; Erick ;   et al. | 2020-01-30 |
Bruton's Tyrosine Kinase Inhibitor Combinations And Uses Thereof App 20200030330 - James; Danelle ;   et al. | 2020-01-30 |
Methods Of Treating And Preventing Graft Versus Host Disease App 20200009148 - Byrd; John C. ;   et al. | 2020-01-09 |
Synthesis Of A Bruton's Tyrosine Kinase Inhibitor App 20190367518 - Ben Haim; Cyril ;   et al. | 2019-12-05 |
Solvated Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20190367519 - Goldman; Erick ;   et al. | 2019-12-05 |
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk) App 20190358234 - Buggy; Joseph J. ;   et al. | 2019-11-28 |
Use of inhibitors of bruton's tyrosine kinase (Btk) Grant 10,478,439 - Honigberg , et al. Nov | 2019-11-19 |
Methods of treating and preventing graft versus host disease Grant 10,463,668 - Byrd , et al. No | 2019-11-05 |
Novel Formulations Of A Bruton's Tyrosine Kinase Inhibitor App 20190282578 - Atluri; Harisha ;   et al. | 2019-09-19 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20190248798 - Purro; Norbert ;   et al. | 2019-08-15 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20190248799 - Purro; Norbert ;   et al. | 2019-08-15 |
Phospholipase C Gamma 2 And Resistance Associated Mutations App 20190203297 - Byrd; John C. ;   et al. | 2019-07-04 |
Formulations Of Histone Deacetylase Inhibitor And Uses Thereof App 20190184196 - Loury; David J. ;   et al. | 2019-06-20 |
Methods For The Treatment Of Her2 Amplified Cancer App 20190167687 - Chen; Jun ;   et al. | 2019-06-06 |
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant 10,294,232 - Purro , et al. | 2019-05-21 |
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant 10,294,231 - Purro , et al. | 2019-05-21 |
Purinone Compounds As Kinase Inhibitors App 20190144451 - Chen; Wei ;   et al. | 2019-05-16 |
Pharmaceutical Formulations Of A Brutons Tyrosine Kinase Inhibitor App 20190117579 - Chong; Ching W. ;   et al. | 2019-04-25 |
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant 10,266,540 - Purro , et al. | 2019-04-23 |
Inhibitors Of Bruton's Tyrosine Kinase App 20190112312 - Chen; Wei ;   et al. | 2019-04-18 |
Inhibitors Of Bruton's Tyrosine Kinase App 20190100505 - Chen; Wei ;   et al. | 2019-04-04 |
Methods of treating fibrosis Grant 10,226,466 - Gonzalez , et al. | 2019-03-12 |
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor Grant 10,213,386 - Chong , et al. Feb | 2019-02-26 |
Pharmaceutical Formulations Of A Bruton's Tyrosine Kinase Inhibitor App 20190015340 - Chong; Ching W. ;   et al. | 2019-01-17 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20180362536 - Purro; Norbert ;   et al. | 2018-12-20 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20180362534 - Purro; Norbert ;   et al. | 2018-12-20 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20180362535 - Purro; Norbert ;   et al. | 2018-12-20 |
Salt or abexinostat, associated crystalline form, a process for their preparation and pharmaceutical compositions containing them Grant 10,150,748 - Pimont-Garro , et al. Dec | 2018-12-11 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20180327415 - Purro; Norbert ;   et al. | 2018-11-15 |
Crystalline forms of a bruton's tyrosine kinase inhibitor Grant 10,125,140 - Purro , et al. November 13, 2 | 2018-11-13 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20180319806 - Purro; Norbert ;   et al. | 2018-11-08 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20180319805 - Purro; Norbert ;   et al. | 2018-11-08 |
Methods Of Treating Abc-dlbcl Using Inhibitors Of Bruton's Tyrosine Kinase App 20180311153 - Buggy; Joseph J. ;   et al. | 2018-11-01 |
Inhibitors Of Brutons Tyrosine Kinase App 20180305348 - Attallah; Gordana B. ;   et al. | 2018-10-25 |
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant 10,106,548 - Purro , et al. October 23, 2 | 2018-10-23 |
Formulations of histone deacetylase inhibitor and uses thereof Grant 10,105,552 - Loury , et al. October 23, 2 | 2018-10-23 |
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk) App 20180280395 - Buggy; Joseph J. ;   et al. | 2018-10-04 |
Pharmaceutical Formulations Of A Bruton's Tyrosine Kinase Inhibitor App 20180250234 - Chong; Ching W. ;   et al. | 2018-09-06 |
Crystalline forms of a bruton's tyrosine kinase inhibitor Grant 10,065,968 - Purro , et al. September 4, 2 | 2018-09-04 |
Inhibitors Of Bruton's Tyrosine Kinase For The Treatment Of Solid Tumors App 20180193345 - Buggy; Joseph J. ;   et al. | 2018-07-12 |
PYRAZOLO[3,4-b]PYRIDINE AND PYRROLO[2,3-b]PYRIDINE INHIBITORS OF BRUTON'S TYROSINE KINASE App 20180194762 - Atallah; Gordana B. ;   et al. | 2018-07-12 |
Methods for the treatment of HER2 amplified cancer Grant 10,016,434 - Chen , et al. July 10, 2 | 2018-07-10 |
Use of inhibitors of Bruton's tyrosine kinase (Btk) Grant 10,016,435 - Buggy , et al. July 10, 2 | 2018-07-10 |
Pharmaceutical formulations of a bruton's tyrosine kinase inhibitor Grant 10,010,507 - Chong , et al. July 3, 2 | 2018-07-03 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20180179214 - Purro; Norbert ;   et al. | 2018-06-28 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20180179215 - Purro; Norbert ;   et al. | 2018-06-28 |
Use of inhibitors of Bruton's tyrosine kinase (Btk) Grant 10,004,746 - Buggy , et al. June 26, 2 | 2018-06-26 |
Use of inhibitors of Bruton'S tyrosine kinase (Btk) Grant 10,004,745 - Buggy , et al. June 26, 2 | 2018-06-26 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20180170940 - Purro; Norbert ;   et al. | 2018-06-21 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20180155352 - Purro; Norbert ;   et al. | 2018-06-07 |
Methods Of Treating Fibrosis App 20180153896 - Gonzalez; Toni Jauset ;   et al. | 2018-06-07 |
Inhibitors Of Bruton's Tyrosine Kinase App 20180085372 - HONIGBERG; LEE ;   et al. | 2018-03-29 |
Methods Of Treating And Preventing Alloantibody Driven Chronic Graft Versus Host Disease App 20180078558 - Blazar; Bruce R. ;   et al. | 2018-03-22 |
Methods Of Treating And Preventing Graft Versus Host Disease App 20180078555 - Byrd; John C. ;   et al. | 2018-03-22 |
Tec Family Kinase Inhibitor Adjuvant Therapy App 20180071293 - Buggy; Joseph J. ;   et al. | 2018-03-15 |
Methods For The Treatment Of Her2 Amplified Cancer App 20180071294 - Chen; Jun ;   et al. | 2018-03-15 |
Bruton's Tyrosine Kinase Inhibitor Combinations And Uses Thereof App 20180071295 - KUO; HSU-PING ;   et al. | 2018-03-15 |
Solvated Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20180072738 - Goldman; Erick ;   et al. | 2018-03-15 |
Purinone Compounds As Kinase Inhibitors App 20180037583 - Chen; Wei ;   et al. | 2018-02-08 |
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk) App 20180036313 - Buggy; Joseph J. ;   et al. | 2018-02-08 |
Phospholipase C gamma 2 and resistance associated mutations Grant 9,885,086 - Byrd , et al. February 6, 2 | 2018-02-06 |
Inhibitors Of Bruton's Tyrosine Kinase App 20180030027 - Chen; Wei ;   et al. | 2018-02-01 |
Novel Formulations of a Bruton's Tyrosine Kinase Inhibitor App 20180028537 - Atluri; Harisha ;   et al. | 2018-02-01 |
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk) App 20180015091 - BUGGY; JOSEPH J. ;   et al. | 2018-01-18 |
Synthesis Of A Bruton?s Tyrosine Kinase Inhibitor App 20180009814 - Benhaim; Cyril ;   et al. | 2018-01-11 |
Inhibitors of Bruton's tyrosine kinase Grant 9,862,722 - Chen , et al. January 9, 2 | 2018-01-09 |
Btk Inhibitor Combinations And Dosing Regimen App 20170360796 - Jaglowski; Samantha M. | 2017-12-21 |
Inhibitors Of Bruton's Tyrosine Kinase App 20170362246 - Buggy; Joseph J. ;   et al. | 2017-12-21 |
Methods of treating fibrosis Grant 9,844,552 - December 19, 2 | 2017-12-19 |
Tlr Inhibitor And Bruton's Tyrosine Kinase Inhibitor Combinations App 20170354655 - Beaupre; Darrin ;   et al. | 2017-12-14 |
Crystalline forms of a bruton's tyrosine kinase inhibitor Grant 9,828,383 - Purro , et al. November 28, 2 | 2017-11-28 |
Formulations Of Histone Deacetylase Inhibitor And Uses Thereof App 20170333731 - Loury; David J. ;   et al. | 2017-11-23 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20170334921 - Purro; Norbert ;   et al. | 2017-11-23 |
Use of inhibitors of bruton'S tyrosine kinase (BTK) Grant 9,814,721 - Buggy , et al. November 14, 2 | 2017-11-14 |
New Salt Of Abexinostat, Associated Crystalline Form, A Process For Their Preparation And Pharmaceutical Compositions Containing Them App 20170313671 - Pimont-Garro; Anne ;   et al. | 2017-11-02 |
Use of inhibitors of bruton's tyrosine kinase (Btk) Grant 9,801,883 - Buggy , et al. October 31, 2 | 2017-10-31 |
Use of inhibitors of bruton's tyrosine kinase (BTK) Grant 9,801,881 - Buggy , et al. October 31, 2 | 2017-10-31 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20170305919 - Purro; Norbert ;   et al. | 2017-10-26 |
Methods of treating and preventing graft versus host disease Grant 9,795,604 - Byrd , et al. October 24, 2 | 2017-10-24 |
Inhibitors of Bruton's tyrosine kinase for the treatment of solid tumors Grant 9,795,605 - Buggy , et al. October 24, 2 | 2017-10-24 |
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk) App 20170266186 - Buggy; Joseph J. ;   et al. | 2017-09-21 |
Novel salts of 3-[(DIMETHYLAMINO)METHYL]-N--1-BENZOFURAN-2-CARBOXAMIDE, related crystalline forms, method for preparing the same and pharmaceutical compositions containing the same App 20170266151 - Gaillard; Marina ;   et al. | 2017-09-21 |
Pharmaceutical Formulations of a Bruton's Tyrosine Kinase Inhibitor App 20170258729 - Chong; Ching W. ;   et al. | 2017-09-14 |
Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors App 20170246169 - Honigberg; Lee ;   et al. | 2017-08-31 |
Bruton's tyrosine kinase inhibitor combinations and uses thereof Grant 9,730,938 - Kuo , et al. August 15, 2 | 2017-08-15 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20170226112 - Purro; Norbert ;   et al. | 2017-08-10 |
Crystalline forms of a bruton's tyrosine kinase inhibitor Grant 9,725,455 - Purro , et al. August 8, 2 | 2017-08-08 |
Methods for the treatment of HER2 amplified cancer Grant 9,724,349 - Chen , et al. August 8, 2 | 2017-08-08 |
TEC family kinase inhibitor adjuvant therapy Grant 9,717,731 - Buggy , et al. August 1, 2 | 2017-08-01 |
Btk Inhibitor Combinations For Treating Multiple Myeloma App 20170209462 - Bilotti; Elizabeth ;   et al. | 2017-07-27 |
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant 9,713,617 - Purro , et al. July 25, 2 | 2017-07-25 |
Inhibitors of bruton's tyrosine kinase Grant 9,708,326 - Chen , et al. July 18, 2 | 2017-07-18 |
Methods for the Treatment of HER2 Amplified Cancer App 20170151243 - Chen; Jun ;   et al. | 2017-06-01 |
Pharmaceutical formulations of a Bruton's tyrosine kinase inhibitor Grant 9,655,857 - Chong , et al. May 23, 2 | 2017-05-23 |
Inhibitors of Bruton's tyrosine kinase Grant 9,656,988 - Chen , et al. May 23, 2 | 2017-05-23 |
Purinone compounds as kinase inhibitors Grant 9,637,487 - Chen , et al. May 2, 2 | 2017-05-02 |
Inhibitors of Bruton's tyrosine kinase Grant 9,624,224 - Chen , et al. April 18, 2 | 2017-04-18 |
Crystalline Forms Of A Bruton's Tyrosine Kinase Inhibitor App 20170100404 - Purro; Norbert ;   et al. | 2017-04-13 |
Novel Formulations of a Bruton's Tyrosine Kinase Inhibitor App 20170079981 - Atluri; Harisha ;   et al. | 2017-03-23 |
Inhibitors of Bruton's tyrosine kinase Grant 9,580,416 - Chen , et al. February 28, 2 | 2017-02-28 |
Inhibitors Of Bruton's Tyrosine Kinase App 20170050970 - Chen; Wei ;   et al. | 2017-02-23 |
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk) App 20170035762 - Buggy; Joseph J. ;   et al. | 2017-02-09 |
Bruton's Tyrosine Kinase Inhibitor Combinations and Uses Thereof App 20170027941 - James; Danelle ;   et al. | 2017-02-02 |
Inhibitors of Bruton's tyrosine kinase Grant 9,556,182 - Honigberg , et al. January 31, 2 | 2017-01-31 |
Inhibitors Of Bruton's Tyrosine Kinase App 20170015671 - Chen; Wei ;   et al. | 2017-01-19 |
Pyrazolo[3,4-d]pyrimidine and pyrazolo[2,3-d]pyrimidine compounds as kinase inhibitors Grant 9,546,172 - Chen , et al. January 17, 2 | 2017-01-17 |
Formulations of a bruton's tyrosine kinase inhibitor Grant 9,545,407 - Shu , et al. January 17, 2 | 2017-01-17 |
Inhibitors Of Bruton's Tyrosine Kinase App 20170007611 - Honigberg; Lee ;   et al. | 2017-01-12 |
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant 9,540,382 - Purro , et al. January 10, 2 | 2017-01-10 |
Pyrrolopyrimidine compounds as kinase inhibitors Grant 9,540,385 - Chen , et al. January 10, 2 | 2017-01-10 |
Inhibitors of Bruton's tyrosine kinase Grant 9,533,991 - Chen , et al. January 3, 2 | 2017-01-03 |
Pyrrolopyrimidine Compounds As Kinase Inhibitors App 20160375026 - Chen; Wei ;   et al. | 2016-12-29 |
Purinone Compounds As Kinase Inhibitors App 20160368924 - Chen; Wei ;   et al. | 2016-12-22 |
Inhibitors Of Bruton's Tyrosine Kinase App 20160355498 - Chen; Wei ;   et al. | 2016-12-08 |
Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof Grant 9,492,423 - Loury , et al. November 15, 2 | 2016-11-15 |
Use Of Inhibitors Of Bruton's Tyrosine Kinase (btk) App 20160324859 - Buggy; Joseph J. ;   et al. | 2016-11-10 |
Purinone compounds as kinase inhibitors Grant 9,469,642 - Chen , et al. October 18, 2 | 2016-10-18 |
Ibrutinib Combination Therapy App 20160287592 - CHANG; Betty ;   et al. | 2016-10-06 |
Pharmaceutical Formulations Of A Bruton's Tyrosine Kinase Inhibitor App 20160256397 - Chong; Ching W. ;   et al. | 2016-09-08 |
Methods Of Treating Abc-dlbcl Using Inhibitors Of Bruton's Tyrosine Kinase App 20160243033 - BUGGY; Joseph J. ;   et al. | 2016-08-25 |
Methods for the treatment of solid tumors Grant 9,421,208 - Balasubramanian August 23, 2 | 2016-08-23 |
Methods for the treatment of HER2 amplified cancer Grant 9,415,050 - Chen , et al. August 16, 2 | 2016-08-16 |
Inhibitors of bruton's tyrosine kinase Grant 9,409,911 - Honigberg , et al. August 9, 2 | 2016-08-09 |
Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy Grant 9,408,816 - Adimoolam , et al. August 9, 2 | 2016-08-09 |
Formulations of histone deacetylase inhibitor and uses therof Grant 9,403,032 - Loury , et al. August 2, 2 | 2016-08-02 |
Methods Of Treating Fibrosis App 20160199376 - GONZ LEZ; Toni Jauset ;   et al. | 2016-07-14 |
Inhibitors of Bruton's tyrosine kinase Grant 9,382,246 - Jia , et al. July 5, 2 | 2016-07-05 |
Use of Inhibitors of Bruton's Tyrosine Kinase (BTK) App 20160175312 - Buggy; Joseph J. ;   et al. | 2016-06-23 |
Indole derivatives as inhibitors of histone deacetylase Grant 9,371,281 - Buggy , et al. June 21, 2 | 2016-06-21 |
Purinone Compounds As Kinase Inhibitors App 20160168149 - Chen; Wei ;   et al. | 2016-06-16 |
Methods For Determining Cancer Resistance To Histone Deacetylase Inhibitors App 20160160286 - BUGGY; Joseph J. ;   et al. | 2016-06-09 |
Crystalline forms of a Bruton's tyrosine kinase inhibitor Grant 9,296,753 - Smyth , et al. March 29, 2 | 2016-03-29 |
Inhibitors of bruton's tyrosine kinase for the treatment of solid tumors Grant 9,278,100 - Honigberg , et al. March 8, 2 | 2016-03-08 |
Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors Grant 9,273,051 - Chen , et al. March 1, 2 | 2016-03-01 |
Inhibitors of Bruton's tyrosine kinase Grant 9,266,893 - Honigberg , et al. February 23, 2 | 2016-02-23 |
Novel Formulations Of A Bruton's Tyrosine Kinase Inhibitor App 20160038496 - SHU; Cassandra ;   et al. | 2016-02-11 |
Biomarkers For The Identification Of Chemosensitivity App 20160040251 - BIRNBAUM; Daniel ;   et al. | 2016-02-11 |
Bruton's Tyrosine Kinase Inhibitor Combinations And Uses Thereof App 20160038495 - KUO; Hsu-Ping ;   et al. | 2016-02-11 |
Biomarkers For Predicting Response Of Dlbcl To Treatment With A Btk Inhibitor App 20160032404 - SCHWEIGHOFER; Karl ;   et al. | 2016-02-04 |
Bet Inhibitor And Bruton's Tyrosine Kinase Inhibitor Combinations App 20160022684 - KUO; Hsu-Ping ;   et al. | 2016-01-28 |
Combinations Of Bruton's Tyrosine Kinase Inhibitors And Cyp3a4 Inhibitors App 20160022683 - FARDIS; Maria ;   et al. | 2016-01-28 |
Btk Inhibitors For The Treatment Of Cns Malignancies App 20160008366 - SUKBUNTHERNG; Juthamas ;   et al. | 2016-01-14 |
Inhibitors Of Bruton's Tyrosine Kinase For The Treatment Of Solid Tumors App 20160000792 - BUGGY; Joseph J. ;   et al. | 2016-01-07 |
Inhibitors Of Bruton's Tyrosine Kinase App 20160002241 - CHEN; Wei ;   et al. | 2016-01-07 |
Biomarker For Predicting Response Of Cll To Treatment With A Btk Inhibitor App 20150361504 - BYRD; John C. ;   et al. | 2015-12-17 |
Inhibitors of Bruton's tyrosine kinase Grant 9,212,185 - Honigberg , et al. December 15, 2 | 2015-12-15 |
Hdac Inhibitor And Btk Inhibitor Combinations App 20150352116 - SAMPATH; Deepa | 2015-12-10 |
Inhibitors of bruton's tyrosine kinase Grant 9,206,189 - Honigberg , et al. December 8, 2 | 2015-12-08 |
Inhibitors of Bruton's tyrosine kinase Grant 9,193,735 - Honigberg , et al. November 24, 2 | 2015-11-24 |
Inhibitors Of Bruton's Tyrosine Kinase App 20150329550 - CHEN; Wei ;   et al. | 2015-11-19 |
Hydroxamates as therapeutic agents Grant 9,186,347 - Verner , et al. November 17, 2 | 2015-11-17 |
Factor VIIa inhibitor Grant 9,181,280 - Dickman , et al. November 10, 2 | 2015-11-10 |
Inhibitors of bruton's tyrosine kinase Grant 9,181,263 - Honigberg , et al. November 10, 2 | 2015-11-10 |
Inhibitors of Bruton's tyrosine kinase Grant 9,181,257 - Honigberg , et al. November 10, 2 | 2015-11-10 |
Inhibitors Of Bruton's Tyrosine Kinase App 20150306106 - HONIGBERG; Lee ;   et al. | 2015-10-29 |
2-(2-hydroxybiphenyl-3-yl)-1H-benzoimidazole-5-carboxamidine derivatives as factor VIIA inhibitors Grant 9,162,986 - Kolesnikov , et al. October 20, 2 | 2015-10-20 |
Inhibitors of bruton's tyrosine kinase Grant 9,139,591 - Honigberg , et al. September 22, 2 | 2015-09-22 |
Inhibitors of Bruton's tyrosine kinase Grant 9,138,436 - Chen , et al. September 22, 2 | 2015-09-22 |
Inhibitors of bruton'S tyrosine kinase Grant 9,133,198 - Honigberg , et al. September 15, 2 | 2015-09-15 |
Inhibitors of bruton's tyrosine kinase Grant 9,133,134 - Chen , et al. September 15, 2 | 2015-09-15 |
NCAGE Code | 7N4W0 | PHARMACYCLICS LLC |
CAGE Code | 7N4W0 | PHARMACYCLICS LLC |
S.A.M. Registration | 7N4W0 [79857498] | PHARMACYCLICS LLC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.